Mgr. Karla Plevová, Ph.D.
Head of the research group, Karla Plevová Research Group: Genomics of Immune Cells
Correspondence Address:
Jihlavská 340/20, 625 00 Brno
Office: bldg. E35/258
Kamenice 753/5
625 00 Brno
Phone: | +420 532 23 4396 |
---|---|
E‑mail: | |
Web: | https://genomika.med.muni.cz/research/research-groups/karla-plevova-group/about-us |
social and academic networks: |
---|
Total number of publications: 357
2017
-
Sada pro detekci přítomnosti mutací v genu ATM u pacientů s CLL
Year: 2017
-
Single cell analysis revealed a coexistence of NOTCH1 and TP53 mutations within the same cancer cells in chronic lymphocytic leukaemia patients
British journal of haematology, year: 2017, volume: 178, edition: 6, DOI
-
Transcriptome sequencing provides novel insights into the biology of chronic lymphocytic leukemia: Focus on major stereotyped subsets
Year: 2017, type: Conference abstract
-
Treatment with BCR inhibitors increases ROR1 expression in CLL cells
Year: 2017, type: Conference abstract
2016
-
Additional trisomies amongst patients with chronic lymphocytic leukemia carrying trisomy 12: the accompanying chromosome makes a difference
Haematologica, year: 2016, volume: 101, edition: 7, DOI
-
Analysis of clonal evolution in chronic lymphocytic leukemia from inactive to symptomatic disease prior treatment using whole-exome sequencing.
Year: 2016, type: Conference abstract
-
Analýza exprese ROR1 proteinu u pacientů s chronickou lymfocytární leukémií
Year: 2016, type: Conference abstract
-
Analýza jednotlivých buněk CLL pacientů se souběžnými mutacemi p53 a NOTCH1.
Year: 2016, type:
-
ATM mutations in major stereotyped subsets of chronic lymphocytic leukemia: Enrichment in subset 2 is associated with markedly short telomeres
Haematologica, year: 2016, volume: 101, edition: 9, DOI
-
Autocrine Signaling by Wnt-5a Deregulates Chemotaxis of Leukemic Cells and Predicts Clinical Outcome in Chronic Lymphocytic Leukemia.
Clinical cancer research, year: 2016, volume: 22, edition: 2, DOI